# Cross-Pollination Manifest: PS → NSE

> **Barrier:** 1
> **Source Pipeline:** Problem-Solving (PS)
> **Target Pipeline:** NASA Systems Engineering (NSE)
> **Created:** 2026-01-31T21:30:00Z
> **Status:** COMPLETE

---

## Purpose

This manifest lists all Problem-Solving pipeline artifacts from Phase 0 that are being shared with the NASA Systems Engineering pipeline for use in Phase 1 and beyond.

**Downstream NSE agents MUST read these artifacts** to ensure informed decision-making based on comprehensive research findings.

---

## Artifacts for Cross-Pollination

### Tier 1a: Original Research

| # | Artifact | Path | Description | Phase 1 Consumer |
|---|----------|------|-------------|------------------|
| 1 | OSS Best Practices Research | `ps/phase-0/ps-researcher/best-practices-research.md` | Comprehensive OSS release patterns, licensing, security, documentation standards. 22 sources cited. | nse-verification (V&V planning), nse-risk (risk update) |
| 2 | Current Architecture Analysis | `ps/phase-0/ps-analyst/current-architecture-analysis.md` | Jerry's hexagonal architecture, 183 Python files, 2,530 tests, dependency analysis. Critical gaps: LICENSE missing, SECURITY.md missing. | nse-verification (baseline), nse-risk (architecture risks) |

### Tier 1b: Expanded Research (DISC-001 Remediation)

| # | Artifact | Path | Description | Phase 1 Consumer |
|---|----------|------|-------------|------------------|
| 3 | Claude Code CLI Best Practices | `ps/phase-0/ps-researcher-claude-code/claude-code-best-practices.md` | Hook system (12 event types), settings hierarchy, MCP overhead (5-20K tokens), Tool Search (46.9% context reduction). 30+ sources. | nse-verification (CLI V&V), nse-risk (API dependency risk) |
| 4 | CLAUDE.md Optimization | `ps/phase-0/ps-researcher-claude-md/claude-md-best-practices.md` | Current: 912 lines (82% over limit). Target: ~300 lines. Context rot research, progressive disclosure tiers. 17 sources. | nse-verification (documentation V&V), nse-risk (context rot risk) |
| 5 | Plugin Architecture | `ps/phase-0/ps-researcher-plugins/plugins-best-practices.md` | Standard structure (`.claude-plugin/plugin.json`), hook types (command, prompt, agent), distribution scopes. 12 sources. | nse-verification (plugin V&V) |
| 6 | Skills Best Practices | `ps/phase-0/ps-researcher-skills/skills-best-practices.md` | SKILL.md requirements (YAML frontmatter, trigger phrases), P-003 constraint (one nesting level), hybrid architecture (1,250x cost reduction). 16 sources. | nse-verification (skills V&V) |
| 7 | Decomposition Patterns | `ps/phase-0/ps-researcher-decomposition/decomposition-best-practices.md` | `.claude/rules/` auto-loading, scoped rules (YAML `paths:`), `@` import syntax (max 5 hops), shell injection (`!`). 17 sources. | nse-verification (decomposition V&V) |

### Shared Artifacts (Both Pipelines)

| # | Artifact | Path | Description | Phase 1 Consumer |
|---|----------|------|-------------|------------------|
| 8 | QG-0 Critic Review v2 | `quality-gates/qg-0/ps-critic-review-v2.md` | Adversarial quality review. Score: 0.931. 4 mandatory findings for Phase 1 resolution. | All Phase 1 agents (quality baseline) |
| 9 | Phase 0 PS Status Report | `reports/phase-0/ps-status-report.md` | Comprehensive status: 7 agents executed, 9 artifacts, 21 risks, 100+ citations, L0/L1/L2 coverage. | nse-reporter (status continuity) |

---

## Key Findings Summary (for NSE Pipeline Consumption)

### Critical Gaps Identified (Must Address Before Release)

1. **RSK-P0-001 (CRITICAL):** Missing LICENSE file - legally required
2. **RSK-P0-002 (HIGH):** Credential exposure risk in git history - requires Gitleaks scan
3. **RSK-P0-003 (HIGH):** Missing SECURITY.md - vulnerability disclosure policy needed
4. **RSK-P0-004 (HIGH):** CLAUDE.md at 912 lines (82% over 500-line recommendation)
5. **RSK-P0-005 (HIGH):** Dual repository sync complexity not defined

### Research Coverage Achieved

- OSS Fundamentals: 100%
- Claude Code Ecosystem: 100%
- Jerry-Specific Analysis: 95% (API dependency risk not explicitly tracked)
- Risk Identification: 95%

### One-Way Door Decisions Confirmed

| Decision | Reversibility | Source |
|----------|---------------|--------|
| MIT License | Very Hard | ps-researcher, nse-explorer |
| Dual Repository Strategy | Hard | nse-explorer |
| Package name `jerry` | Permanent | ps-analyst |
| CLI entry point `jerry` | Permanent | ps-analyst |

---

## Usage Instructions for NSE Agents

### nse-verification (Phase 1)
```
MANDATORY READS:
1. ps/phase-0/ps-analyst/current-architecture-analysis.md (baseline understanding)
2. All Tier 1b research artifacts (verification scope definition)
3. quality-gates/qg-0/ps-critic-review-v2.md (quality findings to address)
```

### nse-risk (Phase 1)
```
MANDATORY READS:
1. All artifacts listed above (comprehensive risk input)
2. risks/phase-0-risk-register.md (existing 21 risks to update)
3. Focus on: API dependency risk, context rot risk, migration risks
```

---

## Traceability

| Source | Destination | Verification |
|--------|-------------|--------------|
| Phase 0 PS artifacts | Phase 1 NSE agents | Agents must cite this manifest |
| ps-critic findings | nse-verification V&V plan | Findings must be addressed |
| Risk register | nse-risk update | Risks must be tracked |

---

*Cross-pollination complete. NSE pipeline has full access to PS Phase 0 findings.*
*Document ID: PROJ-009-ORCH-B1-PS2NSE*
